Physician profile
Janah Aji
NPI 1629164918
$15,645.89
in general payments reported to CMS, 2019-2025
28 companies · $1,650 in 2025
The $1,650 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,741 · 2020: $294 · 2021: $739 · 2022: $1,507 · 2023: $2,469 · 2024: $6,246 · 2025: $1,650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,747 · Travel and Lodging: $3,987 · Consulting Fee: $350 · Long Term Medical Supply Or Device Loan: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,746.67 |
| Travel and Lodging | $3,986.78 |
| Consulting Fee | $350.00 |
| Long Term Medical Supply Or Device Loan | $281.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,197.59 | 2019-2025 | Xience Skypoint, Aveir, Mitraclip |
| Edwards Lifesciences Corporation | $2,919.86 | 2023-2025 | Pascal |
| Medtronic, INC. | $1,782.32 | 2021-2024 | Symplicity G3, Onyx Frontier, Corevalve Evolut R |
| Medtronic Vascular, INC. | $1,008.20 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $945.63 | 2019-2024 | Xarelto |
| Atricure, INC. | $504.59 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Terumo Medical Corporation | $368.76 | 2023-2024 | Glidewire |
| Abiomed | $328.04 | 2019-2025 | Impella |
| Inari Medical, INC. | $245.39 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $206.12 | 2019-2025 | Bodyguardian, Watchman Access System |
| Chiesi USA, INC. | $202.23 | 2022-2025 | Kengreal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $146.44 | 2019-2025 | Lifevest |
| Pfizer INC. | $129.84 | 2019-2025 | |
| Philips North America LLC | $98.81 | 2022-2025 | (Ao0) Igt Devices Intracardiac, Ineb Devices |
| Janssen Pharmaceuticals, INC | $92.10 | 2019-2023 | Xarelto |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agepha Pharma Fz LLC | $83.75 | 2024 | Lodoco |
| Cardiovascular Systems INC. | $73.06 | 2021-2022 | |
| Cardiva Medical, INC. | $58.75 | 2022-2025 | Savvywire |
| Cardinal Health 200 LLC | $40.90 | 2019 | |
| Amgen INC. | $33.09 | 2023 | Repatha |
| W. L. Gore & Associates, INC. | $31.87 | 2022 | |
| Kestra Medical Technology Services, INC. | $30.56 | 2022 | |
| Change Healthcare Technologies, LLC | $25.35 | 2022 | |
| Vital Connect, INC | $24.69 | 2025 | Vitalpatch Rtm |
| Cvrx, INC. | $20.95 | 2025 | Barostim Neo System |
| Medicomp INC | $18.25 | 2025 | Telepatch Cardiac Monitor |
| Stryker Corporation | $14.89 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $13.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janah Aji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.